Mucolipidosis Type IV was first identified as a genetic lysosomal storage disease in 1974. Children with MLIV begin to exhibit developmental delays during the first year of life and many parents often pursue ophthalmologic evaluations for pseudo-strabismus.
MLIV is a genetic disease causing developmental delays, retinal degeneration, gross and small motor dysfunction, and limited lifespan. The Foundation’s mission is to fund, support, and promote medical research dedicated to developing treatments and a cure for MLIV.
Your child’s medical information helps MLIV researchers understand the disease and create treatments. Contact the neurology team at Massachusetts General Hospital to securely share your child’s records! Want to visit for an expert consultation? They can help!
© 2025 Mucolipidosis IV (ML4) Foundation | 877.ML4.5459
